CLINICAL_TRIALS
trial_result
· 2009-07-16
Clinical Trial Update: Optimal Platelet Dose Strategy for Management of Thrombocytopenia [Phase 3]
Summary
Phase 3 clinical trial evaluating the optimal platelet dose strategy for managing thrombocytopenia. Results were posted in July 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Carelon Research | Conditions: Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2009-07-16